Results 11 to 20 of about 228,949 (361)

Multimodality therapy for medulloblastoma [PDF]

open access: yesCancer, 1980
Eight patients with recurrent medulloblastoma were treated with a chemotherapy regimen consisting of vincristine, BCNU, dexamethasone and intrathecal and intermediate dose intravenous methotrexate (500 mg/m2). Five also received local low dose radiotherapy (RT). All 8 patients responded to treatment; 6 completely and 2 partially. These latter 2 were in
P R, Thomas   +5 more
openaire   +2 more sources

A Novel Multimodal Therapy for Anaplastic Thyroid Carcinoma: 125I Seed Implantation Plus Apatinib After Surgery

open access: yesFrontiers in Endocrinology, 2020
Anaplastic thyroid cancer is known to be the most lethal malignancy among endocrine tumors for its extremely limited survival rate after diagnosis.
Yiqi Niu   +6 more
doaj   +1 more source

Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy [PDF]

open access: yes, 2019
The therapeutic management of recurrent malignant gliomas (MGs) is not determined. Therefore, the efficacy of a multimodal approach and a combination systemic therapy was investigated.
Bianco, Vincenzo   +10 more
core   +1 more source

Nanotechnology and photodynamic therapy from a clinical perspective

open access: yesTranslational Biophotonics, 2023
Photodynamic therapy (PDT) is currently applied clinically in many medical centers worldwide. The clinical outcomes are from one side satisfying and from the other side highlighting the areas of further development.
Sara A. Abdel Gaber, Maha Fadel
doaj   +1 more source

Interdisciplinary Radical “En-Bloc” Resection of Ewing Sarcoma of the Chest Wall and Simultaneous Chest Wall Repair Achieves Excellent Long-Term Survival in Children and Adolescents

open access: yesFrontiers in Pediatrics, 2021
Introduction: Ewing sarcomas of the chest wall, historically known as “Askin tumors” represent highly aggressive pediatric malignancies with a reported 5-year survival ranging only between 40 and 60% in most studies.
Alireza Basharkhah   +13 more
doaj   +1 more source

Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review

open access: yesMedicina, 2023
Primary urethral adenocarcinoma in females is an extremely rare malignancy with unclear origin and only a few retrospective cases have been reported. The controversy continues to exist over the origin of primary urethral adenocarcinoma from periurethral ...
Junjie Tian   +6 more
doaj   +1 more source

Urological Chronic Pelvic Pain Syndrome improves when underlying neuromuscular dysfunction is addressed in an outpatient, multimodal treatment protocol

open access: yesJournal of Men's Health, 2022
Background: Urological chronic pelvic pain syndrome (UCPPS) combines two of the most widespread chronic urological pain disorders: interstitial cystitis (IC)/bladder pain syndrome (BPS) and chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS).
Soha Patil   +8 more
doaj   +1 more source

Management of Widespread Pain and Fibromyalgia [PDF]

open access: yes, 2016
Peer reviewedPublisher ...
Basu, Neil   +2 more
core   +2 more sources

Bilateral diffuse choroidal hemangioma in Sturge Weber syndrome: a case report highlighting the role of multimodal imaging and a brief review of the literature [PDF]

open access: yes, 2019
Purpose: The purpose of this paper is to present a patient with bilateral choroidal hemangioma in Sturge-Weber syndrome (SWS) and highlight multimodal imaging techniques for early detection and management of ocular alterations.
Abdolrahimzadeh   +76 more
core   +1 more source

“Three-Bullets” Loaded Mesoporous Silica Nanoparticles for Combined Photo/Chemotherapy

open access: yesNanomaterials, 2019
This contribution reports the design, preparation, photophysical and photochemical characterization, as well as a preliminary biological evaluation of mesoporous silica nanoparticles (MSNs) covalently integrating a nitric oxide (NO) photodonor (NOPD) and
André Luiz Tessaro   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy